|
Bifidobacterium lactis
|
200 million
|
**
|
|
Bifodobacterium longum
|
200 million
|
**
|
|
Bifodabacterium bifidum
|
200 million
|
**
|
|
Streptococcus themophilus
|
400 million
|
**
|
|
Lactobacillus salivarius
|
600 million
|
**
|
|
Lactobacillus rhamnosus
|
600 million
|
**
|
|
Lactobacillus casei
|
600 million
|
**
|
|
Lactobacillus acidophilus
|
1.2 billion
|
**
|
Consult with your doctor before taking any nutritional supplements. These statements
have not been evaluated by the Food and Drug Administration. This information and product
is not intended to diagnose, treat, cure or prevent any disease. It is provided for educational
purposes only and is not intended as medical advice. If you have any concerns you should consult
with an appropriate health professional.
Details:
A combination of 8 different species of beneficial bacteria designed to support gastrointestinal health and immune system function.
Edible Science's 8 strain acidophilus exclusively utilizes the finest strains from Rhodia Incorporated, the world’s leading supplier of high quality probiotic ingredients, and is enteric-coated to ensure that the bacteria in this product are not destroyed in stomach acid but reach the small and large intestines where they are most
beneficial. 8 strain acidophilus is a vegetarian product that contains virtually no lactose.
While there are a multitude of factors involved in healthy digestive function, one of the most important is the delicate balance of bacteria found in the human gastrointestinal (GI) tract. There are three main types of flora in the human GI tract - Bifidobacteria, Bacteroides and Eubacterium. Of slightly less importance are Lactobacilli, Streptococci and Peptococci and other transitory flora1. Our stomachs and intestines are populated by hundreds of billions of these bacteria, or microflora. Amazingly, there are more probiotic organisms in our gut than there are cells in our bodies! That’s a lot of bacteria, but it’s GOOD bacteria, and each strain has specific functions in the human body. These bacteria aid the digestion of food and have protective qualities that contribute to good colon health. While a good balance of these different microflora is necessary, there are many factors that can, and do, disrupt this balance –certain medications, a poor diet, infection, stress, bad bacteria, aging and even the climate. The good news is a rapidly expanding body of research suggests that supplementing the diet with the right mix of microflora can have a beneficial affect on
gastrointestinal function, and therefore overall
health.
The Strains:
Lactobacillus acidophilus is a well-studied microflora species that’s highly resistant to gastric acidity and is
able to proliferate in the presence of bile. Like many probiotic organisms, it also adheres well to intestinal
cells, helping to prevent the adherence of certain enteropathogens.
Lactobacillus casei is a microflora strain that is found in the human mouth and intestines as well as in
fermented vegetables, milk and meat. Recent research has shown that this bacterium is active in the GI tract and may help to modulate the immune system. Research is continuing into this very promising
probiotic.
Lactobacillus rhamnosus, like Lactobacillus acidophilus, is highly resistant to gastric acidity and proliferates
well in bile. It, too, adheres well to intestinal cells. We’ve included this particular strain because it works
extremely well with L. acidophilus.
Lactobacillus salivarius is a strain that has proven highly effective against Helicobacter pylori, a bacterial
species implicated in a number of digestive conditions. Studies have shown that L. salivarius is capable of producing high amounts of lactic acid, which has been shown to inhibit H. pylori growth in live subjects. Compared to other Lactobacillus strains, L. salivarius was proven to have the greatest inhibitory effect on the proliferation of H. pylori,4 which is why this strain is included in our 8 strain acidophilus.
Streptococcus thermophilus bacterium are isolated from yogurt and are recommended for lactose intolerant
individuals to help digest lactose in the intestines. This strain is included in this formula to assist in the acidification of the intestinal environment, as well as to create a favorable environment for lactic acid
bacteria. less importance are Lactobacilli, Streptococci and Peptococci and other transitory flora.
Bifidobacterium bifidum is one of the workhorses of the large intestine. It has a high tolerance to gastric
acidity, and, like L. acidophilus and many other probiotic organisms, it adheres well to intestinal cells,helping to prevent the adherence of certain enteropathogens.
Bifidobacterium longum is a bifidobacterium of human origin that, like lactobacillus, is extremely resistant
to gastric acid and bile salts. Because it’s anaerobic (able to live without oxygen) it’s perfectly suited to colonize the colon. Initial studies have shown that this particular strain of bifidobacteria helps to support the immune system*. It also seems to decrease enzymatic activity in feces. Researchers believe enzymatic activity in feces may contribute to carcinogenesis.
Bifidobacterium lactis is one of the most well-studied strains of probiotic bacteria, with a wealth of peer-reviewed, published research on its benefits. Clinical trials on B. lactis have shown it to be helpful in a number of digestive conditions, including diarrhea and lactose intolerance, as well as immune response modulation.
References
1) Brudnak, Mark A.; The Probiotic Solution: Nature’s Best-Kept Secret for Radiant Health, Dragon Door
Publications, 2003
2) Various Authors; Functional Foods: Designer Foods, Pharmafoods, Nutraceuticals, Edited by Israel
Goldberg; Chapman & Hall, Inc.; 1994
3) Tortora, Gerard J. & Grabowski, Sandra Reynolds; Principles of Anatomy and Physiology – Seventh Edition; Harper Collins, 1993
4) Drisko, J. et. al. Probiotics in health maintenance and disease prevention, Alternative Medicine Review, May, 2003
5) Playne, M. & Salminen, S. Health Benefits of Probiotics: Human studies and clinical trials, Nutrafoods, 2002